Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 4/20 | 0.36 |
| ▸ | DRD2 | P14416 | 4/20 | 0.36 |
| ▸ | DRD3 | P35462 | 4/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HTR7 | P34969 | 1/20 | 0.34 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 1/20 | 0.34 |
| ▸ | RXRB | P28702 | 1/20 | 0.34 |
| ▸ | RXRG | P48443 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.33 |
| ▸ | HTR1A | P08908 | 3/20 | 0.33 |
| ▸ | HTR1B | P28222 | 3/20 | 0.33 |
| ▸ | DRD4 | P21917 | 3/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2455365 | 0.93 | HTR1D (0.39) | HTR1DDRD2DRD3HTR2CHTR7 | |
| Trifluoromethanesulfonic Acid SCHEMBL28049038 | 0.84 | DRD2 (0.35) | HTR1DDRD2DRD3RXRARXRB | |
| SCHEMBL24862607 | 0.77 | CYP3A4 (0.34) | RXRATP53MAPT | |
| SCHEMBL17016644 | 0.76 | KDM4E (0.36) | HTR1DDRD2DRD3HTR2CHTR7 | |
| SCHEMBL12578478 | 0.73 | TP53 (0.39) | RXRARXRBRXRGTP53MAPT | |
| SCHEMBL17016648 | 0.73 | NPSR1 (0.37) | HTR1DDRD2DRD3HTR2CHTR7 | |
| SCHEMBL16811754 | 0.73 | HSD11B1 (0.48) | HTR1DDRD2DRD3HTR2CHTR7 | |
| SCHEMBL31243801 | 0.73 | HSD11B1 (0.48) | HTR1DDRD2DRD3HTR2CHTR7 | |
| SCHEMBL17016647 | 0.71 | HSD11B1 (0.36) | HTR1DDRD2DRD3HTR2CHTR7 | |
| SCHEMBL24862270 | 0.71 | PDK2 (0.37) | TP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9947872-B2 | Hole transport materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2018-04-17 | — | — | US | disclosed |
| US-20170200893-A1 | HOLE TRANSPORT MATERIALS | LG CHEM, LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-9685613-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-06-20 | — | — | US | disclosed |
| US-20130248848-A1 | PROCESS AND MATERIALS FOR MAKING CONTAINED LAYERS AND DEVICES MADE WITH SAME | E.I. DU PONT NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130248847-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200893-A1 | HOLE TRANSPORT MATERIALS | DRD4, AHR, AR | HTR1D 79/4885DRD2 10/4885DRD3 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.